Reduction of deaths after drug labelling for risk of Reye's syndrome.
Davis
D L
DL
Buffler
P
P
D000293:Adolescent; D001241:Aspirin / Q000009:adverse effects*; D002487:Centers for Disease Control and Prevention, U.S.; D002648:Child; D004348:Drug Labeling / Q000592:standards*; D006801:Humans; D012202:Reye Syndrome / Q000139:chemically induced* / Q000401:mortality; D014481:United States
D001241:Aspirin